VEREINIGTE STAATEN VON AMERIKA

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

Retrieved on: 
Freitag, März 24, 2023
ACT, Disclosure, IRISH, Life insurance

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

Key Points: 
  • OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
    Owner or controller of interests and short positions disclosed, if different from 1(a)
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Freitag, März 24, 2023
Disclosure, Mediclinic International, The Vanguard Group, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc

Retrieved on: 
Freitag, März 24, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc

Retrieved on: 
Freitag, März 24, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Donnerstag, März 23, 2023
Disclosure, Mediclinic International, The Vanguard Group, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc

Retrieved on: 
Donnerstag, März 23, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc

Retrieved on: 
Donnerstag, März 23, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

Retrieved on: 
Donnerstag, März 23, 2023
ACT, Disclosure, IRISH, Life insurance

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

Key Points: 
  • OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
    Owner or controller of interests and short positions disclosed, if different from 1(a)
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

Retrieved on: 
Mittwoch, März 22, 2023
ACT, Disclosure, IRISH, Life insurance

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

Key Points: 
  • OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
    Owner or controller of interests and short positions disclosed, if different from 1(a)
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc

Retrieved on: 
Mittwoch, März 22, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.